CORRECTION: Gene Therapy Startup Gets $107M In Series A Round
Gene therapy startup AavantiBio launched on Thursday, after scoring $107 million for the new platform in a Series A financing backed by biotechnology company Sarepta and a group of life science...To view the full article, register now.
Already a subscriber? Click here to view full article